Ultrasound-guided percutaneous nephrolithotomy (PCNL) success rates in patients with elevated body mass index: a comparative study.


Journal

Urolithiasis
ISSN: 2194-7236
Titre abrégé: Urolithiasis
Pays: Germany
ID NLM: 101602699

Informations de publication

Date de publication:
09 Sep 2023
Historique:
received: 11 02 2023
accepted: 22 08 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

Percutaneous nephrolithotomy (PCNL) is considered gold standard treatment of renal stones larger than 20 mm. Several studies have shown that ultrasound guidance during this procedure is more effective and safer than fluoroscopy. A higher body mass index (BMI) can make ultrasound-guided renal access more difficult and unsuccessful. We present a prospective analysis and comparison of ultrasound-guided PCNL in patients with normal and increased body mass index. We performed a prospective comparison of patients who underwent ultrasound-guided PCNL to remove renal stones by a single surgeon between 2020 and 2022. Patients with BMIs greater than 30 (mean 33.87-obese) were compared to those with BMIs less than 30 (mean 25.69-non-obese). Demographic, perioperative, and follow-up data were collected, analyzed, and included in this study. Total of 98 consecutive patients, with 49 patients in each group were analyzed. No statistically significant differences were observed in terms of stone volume (P = 0.085), stone density (P = 0.5590), location of renal access (P = 0.108), surgery duration (P = 0.38), blood loss (P = 0.54), or laboratory changes after surgery (P = 0.60). 87.76% of obese patients were stone free per CT scan at follow-up, compared to 73.47% of normal-weight patients (P = 0.1238). According to Clavien-Dindo classification, six patients in the non-obese group experienced grade II (10%) and grade III (2%) complications, as opposed to six patients in the obese group with grade I (2%), grade II (6%), and grade III (2%) complications. There was no significant correlation between body mass index and the success or safety of ultrasound-guided PCNL. Although more challenging, a higher BMI should not be an impediment to performing this approach. This method is safe, with no increased incidence of postoperative complications or compromise in stone-free status postoperatively and can diminish or avoid both patient's and medical team's exposure to ionizing radiation.

Identifiants

pubmed: 37688633
doi: 10.1007/s00240-023-01485-9
pii: 10.1007/s00240-023-01485-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Semins M, Shore A, Makary M et al (2010) The association of increasing body mass index and kidney stone disease. J Urol 183(2):571–575. https://doi.org/10.1016/j.juro.2009.09.085
doi: 10.1016/j.juro.2009.09.085 pubmed: 20018330
Ekeruo W, Tan Y, Young M et al (2004) Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol 172(1):159–163. https://doi.org/10.1097/01.ju.0000128574.50588.97
doi: 10.1097/01.ju.0000128574.50588.97 pubmed: 15201761
Daudon M, Lacour B, Jungers P (2006) Influence of body size on urinary stone composition in men and women. Urol Res 34(3):193–199. https://doi.org/10.1007/s00240-006-0042-8
doi: 10.1007/s00240-006-0042-8 pubmed: 16474948
Negri A, Spivacow F, Valle E et al (2008) Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res 36(6):303–307. https://doi.org/10.1007/s00240-008-0161-5
doi: 10.1007/s00240-008-0161-5 pubmed: 18985334
Su B, Song H, Yang Z et al (2022) Ultrasound-guided renal access and balloon dilation for PCNL in the prone position: results of a multicenter prospective observational study. World J Urol 40(9):2339–2345. https://doi.org/10.1007/s00345-022-04072-6
doi: 10.1007/s00345-022-04072-6 pubmed: 35821264
Iordache A, Baston C, Cerempei S et al (2018) Ultrasound for kidney access in percutaneous nephrolithotomy: a contemporary review. Med Ultrason 20(4):508–514. https://doi.org/10.11152/mu-1618
doi: 10.11152/mu-1618 pubmed: 30534660
Ganpule A, Vijayakumar M, Malpani A (2016) Percutaneous nephrolithotomy (PCNL) a critical review. Int J Surg 36(Pt D):660–664. https://doi.org/10.1016/j.ijsu.2016.11.028
doi: 10.1016/j.ijsu.2016.11.028 pubmed: 27856356
Fuller A, Razvi H, Denstedt J et al (2012) The CROES percutaneous nephrolithotomy global study: the influence of body mass index on outcome. J Urol 188(1):138–144. https://doi.org/10.1016/j.juro.2012.03.013
doi: 10.1016/j.juro.2012.03.013 pubmed: 22591971
Usawachintachit M, Tzou D, Hu W et al (2017) X-ray–free ultrasound-guided percutaneous nephrolithotomy: how to select the right patient? Urology 100:38–44. https://doi.org/10.1016/j.urology.2016.09.031
doi: 10.1016/j.urology.2016.09.031 pubmed: 27720776
Shaer W, Kandeel W, Lateef S et al (2019) Complete ultrasound-guided percutaneous nephrolithotomy in prone and supine positions: a randomized controlled study. Urology 128:31–37. https://doi.org/10.1016/j.urology.2019.03.004
doi: 10.1016/j.urology.2019.03.004 pubmed: 30902696
Ng F, Yam W, Lim T et al (2017) Ultrasound-guided percutaneous nephrolithotomy: advantages and limitations. Investig Clin Urol 58(5):346–352. https://doi.org/10.4111/icu.2017.58.5.346
doi: 10.4111/icu.2017.58.5.346 pubmed: 28868506 pmcid: 5577331
Lojanapiwat B (2013) The ideal puncture approach for PCNL: fluoroscopy, ultrasound or endoscopy? Indian J Urol 29(3):208–213. https://doi.org/10.4103/0970-1591.117284
doi: 10.4103/0970-1591.117284 pubmed: 24082442 pmcid: 3783701
Bayne D, Usawachintachit M, Tzou D et al (2018) Increasing body mass index steepens the learning curve for ultrasound-guided percutaneous nephrolithotomy. J Urology 120:68–73. https://doi.org/10.1016/j.urology.2018.07.033
doi: 10.1016/j.urology.2018.07.033
Thirugnanasambandam V, Kone K (2021) Flexible nephroscopy: a step towards complete stone clearance in PCNL. J Endolum Endourol 4(1):e13–e16. https://doi.org/10.22374/jeleu.v4i1.112
doi: 10.22374/jeleu.v4i1.112
Skolarikos A Neisius A, Petřík A, Somani B, Thomas K, Gambaro G (2022) EAU Guidelines on Urolithiasis. European Association of Urology; P-31. https://uroweb.org/guidelines/urolithiasis/chapter/introduction . Accessed March 2022.
Obesity and Overweight. Fact sheet No. 311. Updated March 2011. Geneva: World Health Organization. Accessed August 9, 2011.
Curhan G, Willett W, Rimm E et al (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9(9):1645–1652. https://doi.org/10.1681/ASN.V991645
doi: 10.1681/ASN.V991645 pubmed: 9727373
Knoll T, Buchholz N, Nordahl GW (2012) Extracorporeal shockwave lithotripsy vs. percutaneous nephrolithotomy vs. flexible ureterorenoscopy for lower-pole stones. Arab J Urol. 10(3):336–341. https://doi.org/10.1016/j.aju.2012.06.004
doi: 10.1016/j.aju.2012.06.004 pubmed: 26558046 pmcid: 4442916
Uppot R (2018) Technical challenges of imaging & image-guided interventions in obese patients. Br J Radiol 91(1089):20170931. https://doi.org/10.1259/bjr.20170931
doi: 10.1259/bjr.20170931 pubmed: 29869898 pmcid: 6223172
Zhou X, Sun X, Chen X et al (2017) Effect of obesity on outcomes of percutaneous nephrolithotomy in renal stone management: a systematic review and meta-analysis. Urol Int 98(4):382–390. https://doi.org/10.1159/000455162
doi: 10.1159/000455162 pubmed: 28152527
Rule AD, Lieske JC, Li X et al (2014) The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol 25(12):2878–2886. https://doi.org/10.1681/ASN.201309101
doi: 10.1681/ASN.201309101 pubmed: 25104803 pmcid: 4243346
Zeng J, Wang S, Zhong L et al (2019) A retrospective study of kidney stone recurrence in adults. Clin Med Res 11(3):208–212. https://doi.org/10.14740/jocmr3753
doi: 10.14740/jocmr3753
Mazzucchi E, Vicentini FC, Marchini GS et al (2012) Percutaneous nephrolithotomy in obese patients: comparison between the prone and total supine position. J Endourol 26(11):1437–1442. https://doi.org/10.1089/end.2012.0257
doi: 10.1089/end.2012.0257 pubmed: 22721511
Manohar T, Jain P, Desai M (2007) Supine percutaneous nephrolithotomy: effective approach to high-risk and morbidly obese patients. J Endourol 21(1):44–49. https://doi.org/10.1089/end.2006.0212
doi: 10.1089/end.2006.0212 pubmed: 17263606
Li X, Li Y, Li L et al (2018) Obesity increases the risk of complications and costs in patients undergoing percutaneous nephrolithotomy. 97(26):11495
Sefa A, Ozturk T, Aytac R et al (2018) Comparison of the results of retroperitoneoscopic and percutaneous nephrolithotomy in obese patients. Int Urol Nephrol 50(10):1755–1760
Kini A, Okeke S, Ghai S et al (2017) Obesity does not affect the outcome of minimally invasive ureteroscopy for renal and ureteric calculi: a systematic review and meta-analysis. BJU Int 120(2):245–255
Calvary J, Sood S, Shekarriz B et al (2017) Obesity does not affect the outcome of percutaneous nephrolithotomy: a systematic review and meta-analysis. J Endourol 31(6):668–674
Simsek A, Ozgor F, Akbulut MF et al (2014) Does body mass index effect the success of percutaneous nephrolithotomy? Turk J Urol 40:104–109
doi: 10.5152/tud.2014.66674 pubmed: 26328160 pmcid: 4548379
El-Assmy AM, Shokier AA, Moshen T et al (2007) Renal access by urologist or radiologist for percutaneous nephrolithotomy- is it still an issue? J Urol 178:916–920. https://doi.org/10.1016/j.juro.2007.05.015
doi: 10.1016/j.juro.2007.05.015 pubmed: 17632136
Basiri a, Ziaee a, Kianian H, et al (2008) Ultrasonographic versus fluoroscopic access for percutaneous nephrolithotomy: a randomized clinical trial. J Endourol 22(2):281–284. https://doi.org/10.1089/end.2007.0141
doi: 10.1089/end.2007.0141 pubmed: 18294034
Chi Q, Wang Y, Lu J et al (2014) Ultrasonography combined with fluoroscopy for percutaneous nephrolithotomy: an analysis based on seven years single center experiences. Urol J 11(1):1216–1221
pubmed: 24595927

Auteurs

Dolev Perez (D)

Department of Urology, Shaare Zedek Medical Center, P.O.B 3235, 91031, Jerusalem, Israel. drdolevperez@gmail.com.

Binyamin B Neeman (BB)

Department of Urology, Shaare Zedek Medical Center, P.O.B 3235, 91031, Jerusalem, Israel.

David Dotan (D)

Department of Urology, Shaare Zedek Medical Center, P.O.B 3235, 91031, Jerusalem, Israel.

Galiya Raisin (G)

Department of Urology, Shaare Zedek Medical Center, P.O.B 3235, 91031, Jerusalem, Israel.

Boris Chertin (B)

Department of Urology, Shaare Zedek Medical Center, P.O.B 3235, 91031, Jerusalem, Israel.

Ilan Kafka (I)

Department of Urology, Shaare Zedek Medical Center, P.O.B 3235, 91031, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH